Lmr Partners LLP Global Blood Therapeutics, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $350,308 - $468,588	-10,792 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $420,240 - $548,773	10,792 New	10,792 $440,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $816,741 - $1.38 Million	-21,693 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $201,965 - $285,147	-3,828 Reduced 15.0%	21,693 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $1.24 Million - $2.09 Million	25,521 New	25,521 $1.61 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.